Net (Loss)/Income Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Net (Loss)/Income Per Share

Schedule of computation of basic and diluted net (loss)/income per share

The following table sets forth the computation of basic and diluted net (loss)/income per share for the three months ended March 31, 2023, and 2022 (in thousands, except number of shares):

	Three months ended March 31,
	2023			2022
Numerator:
Net (loss)/income	$	(18,223)	$	2,574
Net loss attributable to noncontrolling interest		43		22
Net (loss)/income attributable to Vaccitech shareholders	$	(18,180)	$	2,596
Denominator:
Weighted-average ordinary shares outstanding, basic		38,013,399		37,191,022
Effect of dilutive stock options		—		1,155,646
Weighted-average ordinary shares outstanding, diluted		38,013,399		38,346,668
Net (loss)/income per share attributable to ordinary shareholders, basic	$	(0.48)	$	0.070
Net (loss)/income per share attributable to ordinary shareholders, diluted	$	(0.48)	$	0.068